Immunotherapy biotech BeneVir Biopharm raises $2 million – Washington Business Journal
Washington Business Journal |
Immunotherapy biotech BeneVir Biopharm raises $2 million
Washington Business Journal It’s yet another approach in the increasingly hot field of immunotherapy, which harnesses the immune system to attack disease. More commonly recognized approaches include checkpoint inhibitor therapies such as Keytruda or Opdivo, which target … |
GeekWire |
Inside Seattle Children’s landmark $1B campaign to cure childhood cancer and other diseases
GeekWire Seattle Children’s has already developed several immunotherapy treatments, most of which are CAR T immunotherapies that genetically reprogram immune cells to fight cancer. One of those is now the flagship treatment of Seattle-based Juno Therapeutics, … |